$543.60
1.02% yesterday
Nasdaq, Dec 11, 10:11 pm CET
ISIN
US46120E6023
Symbol
ISRG
Sector

Intuitive Surgical Target price 2024 - Analyst rating & recommendation

Intuitive Surgical Classifications & Recommendation:

Buy
71%
Hold
29%

Intuitive Surgical Price Target

Target Price $559.25
Price $543.60
Potential 2.88%
Number of Estimates 24
24 Analysts have issued a price target Intuitive Surgical 2025 . The average Intuitive Surgical target price is $559.25. This is 2.88% higher than the current stock price. The highest price target is $650.00 19.57% , the lowest is $475.00 12.62% .
A rating was issued by 31 analysts: 22 Analysts recommend Intuitive Surgical to buy, 9 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Intuitive Surgical stock has an average upside potential 2025 of 2.88% . Most analysts recommend the Intuitive Surgical stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028


Dec '23 2024
Estimates
Revenue Billion $ 7.12 8.15
14.49% 14.33%
EBITDA Margin 30.91% 41.59%
1.75% 34.56%
Net Margin 25.15% 26.28%
20.36% 4.49%

25 Analysts have issued a sales forecast Intuitive Surgical 2024 . The average Intuitive Surgical sales estimate is $8.1b . This is 3.54% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $8.2b 4.19% , the lowest is $8.1b 2.68% .

This results in the following potential growth metrics:

Revenue Estimates

2023 $7.1b 14.49%
2024 $8.1b 14.33%
2025 $9.5b 16.92%
2026 $11.0b 15.65%
2027 $12.6b 14.55%
2028 $14.5b 15.12%

17 Analysts have issued an Intuitive Surgical EBITDA forecast 2024. The average Intuitive Surgical EBITDA estimate is $3.4b . This is 34.66% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $4.1b 62.27% , the lowest is $3.1b 23.28% .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $2.2b 12.49%
2024 $3.4b 53.83%
2025 $4.0b 18.44%
2026 $4.7b 16.26%
2027 $5.4b 16.18%
2028 $6.4b 17.29%

EBITDA Margin

2023 30.91% 1.75%
2024 41.59% 34.56%
2025 42.13% 1.30%
2026 42.35% 0.52%
2027 42.95% 1.42%
2028 43.76% 1.89%

9 Intuitive Surgical Analysts have issued a net profit forecast 2024. The average Intuitive Surgical net profit estimate is $2.1b . This is 3.40% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $2.2b 0.30% , the lowest is $2.1b 5.95% .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $1.8b 37.81%
2024 $2.1b 19.46%
2025 $2.5b 16.55%
2026 $2.9b 17.47%
2027 $3.5b 17.84%
2028 $3.7b 8.21%

Net Margin

2023 25.15% 20.36%
2024 26.28% 4.49%
2025 26.19% 0.34%
2026 26.61% 1.60%
2027 27.37% 2.86%
2028 25.73% 5.99%

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028


Dec '23 2024
Estimates
Earnings Per Share $ 5.03 6.01
37.81% 19.48%
P/E 89.55
EV/Sales 23.02

9 Analysts have issued a Intuitive Surgical forecast for earnings per share. The average Intuitive Surgical <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is $6.01 . This is 3.38% lower than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is $6.24 0.32% , the lowest is $5.85 5.95% .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $5.03 37.81%
2024 $6.01 19.48%
2025 $7.00 16.47%
2026 $8.23 17.57%
2027 $9.69 17.74%
2028 $10.49 8.26%

P/E ratio

Current 86.49 18.32%
2024 89.55 3.54%
2025 76.83 14.20%
2026 65.41 14.86%
2027 55.51 15.14%
2028 51.30 7.58%

Based on analysts' sales estimates for 2024, the Intuitive Surgical stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 23.02 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 23.53 .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 23.84 58.72%
2024 23.02 3.43%
2025 19.69 14.47%
2026 17.03 13.53%
2027 14.86 12.70%
2028 12.91 13.13%

P/S ratio

Current 24.36 52.71%
2024 23.53 3.42%
2025 20.12 14.47%
2026 17.40 13.53%
2027 15.19 12.70%
2028 13.20 13.13%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today